A detailed history of Cva Family Office, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 115 shares of BIIB stock, worth $17,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115
Previous 313 63.26%
Holding current value
$17,137
Previous $72,000 69.44%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$189.07 - $236.8 $37,435 - $46,886
-198 Reduced 63.26%
115 $22,000
Q2 2024

Jul 09, 2024

BUY
$190.52 - $236.72 $32,578 - $40,479
171 Added 120.42%
313 $72,000
Q1 2024

Apr 10, 2024

BUY
$212.02 - $267.71 $424 - $535
2 Added 1.43%
142 $30,000
Q4 2023

Jan 16, 2024

BUY
$222.59 - $267.94 $31,162 - $37,511
140 New
140 $36,000
Q2 2023

Jul 10, 2023

BUY
$275.25 - $318.06 $2,752 - $3,180
10 Added 9.52%
115 $32,000
Q1 2023

Apr 26, 2023

SELL
$256.56 - $292.34 $5,131 - $5,846
-20 Reduced 16.0%
105 $29,000
Q4 2022

Feb 21, 2023

BUY
$252.44 - $306.72 $5,048 - $6,134
20 Added 19.05%
125 $34,000
Q3 2022

Nov 22, 2022

BUY
$194.69 - $268.46 $6,814 - $9,396
35 Added 50.0%
105 $28,000
Q2 2022

Jul 11, 2022

SELL
$187.54 - $223.02 $4,688 - $5,575
-25 Reduced 26.32%
70 $14,000
Q1 2022

Apr 22, 2022

BUY
$193.77 - $244.14 $968 - $1,220
5 Added 5.56%
95 $20,000
Q4 2021

Jan 25, 2022

BUY
$223.92 - $287.77 $20,152 - $25,899
90 New
90 $22,000
Q3 2021

Oct 12, 2021

SELL
$282.99 - $369.05 $41,033 - $53,512
-145 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$259.0 - $414.71 $9,065 - $14,514
35 Added 31.82%
145 $50,000
Q1 2021

Apr 14, 2021

BUY
$242.95 - $284.63 $26,724 - $31,309
110 New
110 $31,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.